Ronald B Franklin Selected Research

5- ((2,4- dioxo- 5- thiazolidinyl)methyl)- 2- methoxy- N- ((4- (trifluoromethyl)phenyl)methyl)benzamide

9/2006

Absorption, metabolism, and excretion of [14C]MK-0767 (2-methoxy-5-(2,4-dioxo-5-thiazolidinyl)-N-[[4-(trifluoromethyl)phenyl] methyl]benzamide) in humans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ronald B Franklin Research Topics

Disease

4	Type 2 Diabetes Mellitus (MODY) 09/2006 - 01/2004
1	Flushing 02/2007
1	Hyperglycemia 02/2005
1	Insulin Resistance 02/2005
1	Nausea 02/2004
1	Vomiting 02/2004
1	Dyslipidemias (Dyslipidemia) 01/2004

Drug/Important Bio-Agent (IBA)

3	MK0767IBA 09/2006 - 01/2004
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 09/2006 - 01/2004
3	benzamideIBA 09/2006 - 01/2004
2	2,4-thiazolidinedione (thiazolidinedione)IBA 09/2006 - 01/2005
2	PPAR alphaIBA 01/2005 - 01/2004
1	Acetic Acid (Vinegar)FDA LinkGeneric 02/2007
1	Niacin (Nicotinic Acid)FDA LinkGeneric 02/2007
1	ProstaglandinsIBA 02/2007
1	5- ((2,4- dioxo- 5- thiazolidinyl)methyl)- 2- methoxy- N- ((4- (trifluoromethyl)phenyl)methyl)benzamideIBA 09/2006
1	PPAR gammaIBA 02/2005
1	Neurokinin-1 Receptor AntagonistsIBA 02/2004
1	Aprepitant (Emend)FDA Link 02/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 02/2004